We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+0.17%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$3.81B
AUM Growth
+$1.88B
(+98%)
Cap. Flow
+$1.94B
Cap. Flow
% of AUM
50.99%
Top 10 Holdings %
Top 10 Hldgs %
5.52%
Holding
3,983
New
1,493
Increased
1,108
Reduced
652
Closed
727
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$25.6M |
| 2 |
JPMorgan Chase
JPM
|
+$21.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$19.7M |
| 4 |
Kroger
KR
|
+$17.9M |
| 5 |
T-Mobile US
TMUS
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$11.3M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$8.42M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$8.34M |
| 4 |
Cisco
CSCO
|
+$8.02M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$8.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.84% |
| 2 | Technology | 16.54% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 11.32% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOBO
3151
Lobo Technologies Ltd
LOBO
$10.5M
| $12.4K | ﹤0.01% |
20,151
-15,790
| -44% | -$12.5K |
|
|
NAMM
3152
Namib Minerals
NAMM
$75.2M
| $12.3K | ﹤0.01% |
+12,224
| New | +$22.5K |
|
3153
NextPlat
NXPL
$16.1M
| $12.3K | ﹤0.01% |
2,309
+707
| +44% | +$5.04K |
|
|
LAZR
3154
DELISTED
Luminar Technologies
LAZR
| $12.2K | ﹤0.01% |
+152,521
| New | +$200K |
|
|
LGO
3155
Largo
LGO
$60.5M
| $12.2K | ﹤0.01% |
12,978
-19,152
| -60% | -$22.7K |
|
|
PN
3156
PN Smart Energy Ltd
PN
$127M
| $12K | ﹤0.01% |
+832
| New | +$12.2K |
|
|
BSLK
3157
DELISTED
Bolt Projects Holdings
BSLK
| $12K | ﹤0.01% |
+14,964
| New | +$35.2K |
|
|
PPCB
3158
Propanc Biopharma
PPCB
$2.76M
| $11.9K | ﹤0.01% |
+885
| New | +$24.5K |
|
|
BTOC
3159
Armlogi Holding Corp
BTOC
$11.2M
| $11.8K | ﹤0.01% |
+22,730
| New | +$14.5K |
|
|
TGHL
3160
The GrowHub Ltd
TGHL
$16M
| $11.8K | ﹤0.01% |
+35,706
| New | +$26.5K |
|
|
BYAH
3161
Park Ha Biological Technology Co
BYAH
$2.26M
| $11.8K | ﹤0.01% |
1,483
+612
| +70% | +$9.28K |
|
3162
Guardforce AI
GFAI
$9.93M
| $11.7K | ﹤0.01% |
+21,135
| New | +$19.1K |
|
3163
Jaguar Health
JAGX
$4.74M
| $11.6K | ﹤0.01% |
+391
| New | +$20.1K |
|
|
PASW
3164
Ping An Biomedical
PASW
$15.3M
| $11.6K | ﹤0.01% |
+23,079
| New | +$15.4K |
|
|
GLE
3165
Global Engine Group
GLE
$6.51M
| $11.6K | ﹤0.01% |
+33,040
| New | +$18K |
|
|
PMA
3166
Ming Shing Group
PMA
$16.3M
| $11.5K | ﹤0.01% |
11,480
-6,422
| -36% | -$11.7K |
|
|
ADIL
3167
Adial Pharmaceuticals
ADIL
$6.46M
| $11.5K | ﹤0.01% |
+2,084
| New | +$16.9K |
|
|
WCT
3168
Wellchange Holdings
WCT
$3.99M
| $11.3K | ﹤0.01% |
+1,408
| New | +$18.6K |
|
3169
Cenntro
CENN
$8.51M
| $11.1K | ﹤0.01% |
1,358
+627
| +86% | +$8.03K |
|
3170
Xilio Therapeutics
XLO
$60.2M
| $11.1K | ﹤0.01% |
1,236
-4,196
| -77% | -$44.1K |
|
3171
Snail Inc
SNAL
$44.7M
| $11K | ﹤0.01% |
+2,476
| New | +$12.2K |
|
|
RTB
3172
RTB Digital
RTB
$256M
| $10.9K | ﹤0.01% |
1,915
+1,296
| +209% | +$14.3K |
|
3173
CXApp
CXAI
$13.7M
| $10.9K | ﹤0.01% |
32,712
-1,134
| -3% | -$651 |
|
|
IMRN
3174
Immuron
IMRN
$8.8M
| $10.8K | ﹤0.01% |
14,116
-3,852
| -21% | -$6.35K |
|
3175
Biofrontera
BFRI
$14.2M
| $10.8K | ﹤0.01% |
18,867
+864
| +5% | +$781 |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q4 2025 Portfolio in Review
As of Q4 2025, XTX Topco held 3,983 positions worth $3.81B, up 98% from $1.93B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
XTX Topco deployed $1.94B of net new capital in Q4 2025, opening 1,493 new positions and adding to 1,108 existing holdings. Its largest new stake was T-Mobile US: 74,738 shares worth $15.2M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.34M trimmed.
- XTX Topco's largest Q4 2025 buy was T-Mobile US: 74,738 shares worth $15.2M.
- XTX Topco added most to Procter & Gamble in Q4 2025, an estimated $25.6M increase.
- XTX Topco's biggest Q4 2025 reduction was Bristol-Myers Squibb, cutting an estimated $8.34M.
- XTX Topco fully exited Johnson & Johnson in Q4 2025, selling an estimated $11.3M.
- XTX Topco's ten largest holdings make up 5.5% of its $3.81B portfolio in Q4 2025.
- XTX Topco opened 1,493 new positions and closed 727 in Q4 2025.
- XTX Topco's portfolio value rose 98% quarter-over-quarter to $3.81B.
Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.